Stankiewicz James M, Brass Steven D
Partners MS center, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts 02445, USA.
Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):22-9. doi: 10.1097/MCO.0b013e32831ba07c.
To explore the role of iron physiology in the brain of healthy adults and review how increased brain iron deposition has been associated with common neurodegenerative diseases that affect the elderly.
Because iron plays a role in oxygen transportation, myelin synthesis, neurotransmitter production, and electron transfers, it serves as a crucial cofactor in normal central nervous metabolism. However, an increased level of brain iron may promote neurotoxicity due to free radical formation, lipid peroxidation, and ultimately, cellular death. Advanced neuroimaging techniques and pathological studies have demonstrated increased brain iron with aging, and increased iron deposition has also been observed in patients with a constellation of neurological diseases, including Alzheimer's disease, Parkinson's disease, and stroke.
Pathologic and neurologic imaging coupled with experimentation have increased our understanding of the link between iron and neurodegeneration. A potential implication is that disease-modifying therapies aimed at removing excess iron may one day be part of the armamentarium employed by clinicians to decrease the burden of neurodegenerative diseases in the elderly.
探讨铁生理学在健康成年人脑内的作用,并综述脑铁沉积增加如何与影响老年人的常见神经退行性疾病相关联。
由于铁在氧气运输、髓鞘合成、神经递质产生和电子传递中发挥作用,它是正常中枢神经代谢中的关键辅助因子。然而,脑铁水平升高可能因自由基形成、脂质过氧化并最终导致细胞死亡而促进神经毒性。先进的神经成像技术和病理学研究已证明脑铁随年龄增长而增加,并且在患有一系列神经疾病(包括阿尔茨海默病、帕金森病和中风)的患者中也观察到铁沉积增加。
病理学和神经影像学结合实验增进了我们对铁与神经退行性变之间联系的理解。一个潜在的意义是,旨在去除过量铁的疾病修饰疗法可能有朝一日会成为临床医生用以减轻老年人神经退行性疾病负担的手段之一。